Depression at Psych Congress 2026
10 sessions on depression · September 15–19, 2026, New Orleans, LA. Compare depression at other meetings →
Tuesday, September 15
Symposium · Pediatric Psychiatry
Rethinking Pediatric Depression: Early Identification and Emerging Treatments
Adelaide S. Robb · Julie Carbray · Liv Lewis
Reviews atypical presentations of youth depression and newer options including rapid-acting agents and digital therapeutics, with strategies for early detection in schools and primary care and a lived-experience perspective.
Symposium · Solving Clinical Challenges
Solving Clinical Challenges: Managing Major Depressive Disorder When First-Line Treatments Fall Short
Brittany Albright · Rebecca Barbee · Kristian Dambrino
Case-based walkthrough of evaluating apparent treatment resistance in MDD — uncovering hidden contributors like anxiety, trauma, and medical illness — and choosing among optimization, augmentation, and switching pathways.
Wednesday, September 16
Symposium · MasterClass
MasterClass: Across Mood Episodes and Throughout the Lifespan: Atypical Antipsychotic Strategies for MDD and Bipolar Disorder
Gregory Mattingly · Desiree Matthews
Case-driven review of selecting atypical antipsychotics across mood episodes, weighing efficacy, tolerability, adherence, and patient-specific factors.
Symposium · MasterClass
MasterClass: The Road to Recovery in MDD: From Partial Response to Remission and Beyond
Christoph U. Correll · Brooke Kempf
Focuses on recognizing clinically meaningful residual depressive symptoms and using adjunctive pharmacologic options to push partial responders toward remission and sustained recovery.
Thursday, September 17
Symposium · Latest Discoveries & Emerging Trends
Latest Discoveries & Emerging Trends in MDD
Year-in-review of depression research spanning neurobiology, trial results, and pharmacologic and non-pharmacologic innovation, with selected poster presenters showcasing new data.
Symposium · MasterClass
MasterClass: Unlocking the Doors of Depression: Neuroplastic and Psychedelic Therapies in MDD
Examines glutamatergic and serotonergic neuroplasticity pathways and the evidence base for investigational psychedelic and psychedelic-assisted therapies in major depression.
Symposium · MasterClass
MasterClass: Volition Reignition: Achieving Patient Goals by Detecting and Addressing Anhedonia in MDD
Brittany Albright · Veronica Ridpath
Focuses on reward-system dysfunction in depression, practical assessment of anhedonia, and emerging therapies aimed at restoring motivation and meaningful recovery.
Measurement-Based Care & Diagnosis · Neuroscience & Mechanisms
Friday, September 18
Symposium · Interventional Psychiatry
Neuromodulation for Depression: Matching the Right Treatment to the Right Patient
Four case scenarios guide selection among TMS, ECT, VNS, theta-burst, and accelerated protocols, comparing mechanisms, indications, and sequencing within overall treatment plans.
Symposium · MDD
Modern Psychopharmacology for MDD: Switching, Sequencing, and Augmentation Strategies for Partial Responders
Mark Zimmerman · Shelley Matthews
Advanced review of switching protocols, cross-tapering, and augmentation options — lithium, T3, atypicals, dextromethorphan/bupropion, vortioxetine — for patients with incomplete antidepressant response.
Lithium & Mood Stabilizers · Novel Antidepressants · Treatment-Resistant Depression
Saturday, September 19
Lecture · MDD
Inflammatory and Immune-Driven Depression: CRP, Biomarkers, and Anti-Inflammatory Treatment Pathways
Reviews the inflammatory depression phenotype and CRP-guided antidepressant selection, plus anti-inflammatory, glutamatergic, microbiome, and lifestyle interventions targeting immune activity.
Inflammation & Immunopsychiatry · Lifestyle & Integrative Psychiatry · Pharmacogenomics & Precision Psychiatry
Other topics at this meeting
Neuroscience & Mechanisms 10Schizophrenia & Psychosis 9Measurement-Based Care & Diagnosis 8Drug Pipeline & Clinical Trials 7Sleep & Insomnia 7ADHD 6Bipolar Disorder 6Drug Interactions & Safety 6Lifestyle & Integrative Psychiatry 6Psychotherapy 6Antipsychotic Prescribing 5Anxiety Disorders 5